Company Profile

Celsense Inc
Profile last edited on: 12/30/19      CAGE: 4RBM8      UEI: F1W7G1FLD9S5

Business Identifier: Magnetic resonance imaging contrast agents
Year Founded
2005
First Award
2008
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

603 Stanwix Street Suite 348
Pittsburgh, PA 15222
   (412) 263-2870
   info@celsense.com
   www.celsense.com
Location: Single
Congr. District: 18
County: Allegheny

Public Profile

Celsense, Inc., a biotechnology company working in the cellular imaging space offers magnetic resonance imaging (MRI) contrast agents that enable scientists and clinicians to monitor the position and quantity of transplanted cells non-invasively in vivo. The firm's products include Cell Sense, a MRI cell tracer reagent; Gene Sense, a proprietary DNA-encoded marker that genetically programs cells to express their own contrast agent; V-sense, a fluorine-based MRI tracer agent, as well as Workstation software platform, a Windows based image management system; and Voxel Tracker that allows researchers to manipulate and quantify molecular imaging data by merging images produced from various imaging scanners. The company’s products are used to monitor the inflammation and administration of cellular therapeutics, such as regenerative cell therapies that repair damaged and diseased organs and immunologic therapies to treat cancer. Its products are also used as in vivo diagnostics to track cancer metastases and immune system response.Celsense was founded to commercialize imaging platforms developed at Carnegie Mellon University.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Charlie OHanlon -- President

  Eric T Ahrens -- Founder and Chief Scientific Officer

  T Ronald Casper -- Secretary, Treasurer and Chief Financial Officer

  Lourdes M Castellanos -- Controller

  Brook Marie Helfer -- Director of Research and Development

  Jelena M Janjic

  Robbie B Mailliard

  Charles F O'hanlon

  Amy K Wesa -- Director of Research and Development